HGC Investment Management Inc.
•CIK: 1711200•Filing: Q4 2025
**HGC Investment Management Inc.** manages $472M across a diversified portfolio of 160 positions. The firm exhibits concentrated exposure, notably holding MS-PL across multiple tranches, including a $15.4M position. Significant allocations are also evident in TDBCP ($15.4M) and GSCE ($15.4M), suggesting targeted conviction in these names. This structure indicates a disciplined, high-conviction approach to capital deployment.
Total AUM
$471.7M
QoQ Performance
+14.9%
Positions
156
Top 10 Concentration
26.7%
Latest Filing
Q4 2025
Top Holdings Allocation
ARTIUS3.3%
CENTURION3.3%
JACKSON3.3%
GP-ACT3.1%
SIDDHI2.7%
DRUGS2.6%
FIFTH2.5%
OXLEY2.1%
📈 Biggest Buys
—
DRUGS MADE IN AMERICA ACQUIS
NEW
2.6% of portfolio
—
PYROPHYTE ACQUISITION CORP-A
NEW
1.8% of portfolio
EXK
EXACT SCIENCES CORP
NEW
1.7% of portfolio
—
ITHAX ACQUISITION CORP III
NEW
1.7% of portfolio
—
LAUNCHPAD CADENZA ACQUISITIO
NEW
1.6% of portfolio
📉 Biggest Sells
—
AMERICAN EXCEPTIONALISM-CL A
-98.6%
0.0% of portfolio
—
AA MISSION ACQUISITION COR-A
-49.8%
1.4% of portfolio
—
CANTOR EQUITY PARTNERS-CL A
-48.0%
1.4% of portfolio
—
LIVE OAK ACQUISITION CORP-A
-93.8%
0.1% of portfolio
—
SOULPOWER ACQUISITION CO-A
-26.9%
2.1% of portfolio
Sector Breakdown
Other100.0%
🚪 Exited Positionssold since Q3 2025
—
DRUGS MADE IN AMERICA ACQUIS
SOLD
$11.9M
—
PYROPHYTE ACQUISITION CORP I
SOLD
$8.6M
—
CARTESIAN GROWTH CORP III
SOLD
$8.1M
—
JENA ACQUISITION CORP II
SOLD
$7.3M
+19 more exited positions
Changes from Q3 2025
NEW61 new positions
↑4 increased
↓20 decreased
Historical Filings
Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023